Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | RECQL | P46063 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.37 |
| ▸ | LMNA | P02545 | 3/20 | 0.37 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.37 |
| ▸ | HPGD | P15428 | 2/20 | 0.37 |
| ▸ | TSHR | P16473 | 4/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.35 |
| ▸ | USP2 | O75604 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | FAAH | O00519 | 1/20 | 0.35 |
| ▸ | MGLL | Q99685 | 1/20 | 0.35 |
| ▸ | GRM5 | P41594 | 2/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | GRM3 | Q14832 | 1/20 | 0.35 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3981450 | 0.89 | SMN1; SMN2 (0.43) | SMN1; SMN2MAPTPOLBRECQLL3MBTL1 | |
| SCHEMBL3985459 | 0.88 | SMN1; SMN2 (0.40) | SMN1; SMN2POLBRECQLL3MBTL1LMNA | |
| SCHEMBL3982263 | 0.88 | SMN1; SMN2 (0.40) | SMN1; SMN2MAPTPOLBRECQLL3MBTL1 | |
| SCHEMBL3987185 | 0.88 | SMN1; SMN2 (0.40) | SMN1; SMN2POLBRECQLL3MBTL1LMNA | |
| SCHEMBL3989708 | 0.88 | SMN1; SMN2 (0.40) | SMN1; SMN2POLBRECQLL3MBTL1LMNA | |
| SCHEMBL3983923 | 0.86 | SMN1; SMN2 (0.38) | SMN1; SMN2POLBRECQLL3MBTL1LMNA | |
| SCHEMBL3982232 | 0.84 | ALDH1A1 (0.38) | SMN1; SMN2POLBRECQLL3MBTL1LMNA | |
| SCHEMBL3985775 | 0.84 | ADORA1 (0.37) | SMN1; SMN2POLBRECQLL3MBTL1LMNA | |
| SCHEMBL3991465 | 0.83 | ALDH1A1 (0.37) | SMN1; SMN2MAPTPOLBRECQLL3MBTL1 | |
| SCHEMBL3981562 | 0.82 | MAPT (0.37) | MAPTPOLBTP53PKMNPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1756114-B1 | HIV INTEGRASE INHIBITORS | MERCK SHARP & DOHME (US) | 2014-11-19 | — | — | EP | disclosed |
| US-7538112-B2 | HIV integrase inhibitors | MERCK & CO., INC. (US) | 2009-05-26 | — | — | US | disclosed |
| US-20080287394-A1 | Hiv Integrase Inhibitors | MERCK & CO., INC. (US) | 2008-11-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080287394-A1 | Hiv Integrase Inhibitors | DHPS, DPYD, TYMP | SMN1; SMN2 4264/4885MAPT 3743/4885POLB 80/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.